2[1]Campanacei M.Bone and soft tissue tumors:clinical features,imaging,pathology and treatment[M].New York:Springer,1999:160.
3[3]DiCaprio MR,Enneking WF.Fibrous dysplasia.Pathophysiolagy,evaluation,and treatment[J].J Bone Joint Surg Am,2005,87(8):1848-1864.
4[4]Brannon RB,Fowler CB.Benign fibro-osseous lesions:a review of current concepts[J].Adv Anat Pathol,2001,8(3):126-143.
5[5]Marie PJ,de Pollak C,Chanson P,et al.Increased proliferation of osteoblastie cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia[J].Am J Patbol,1997,150(3):1059-1069.
6[6]Shenker A,Weinstein LS,Sweet DE,et al.An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCuneAlbright syndrome[J].J Clin Endocrinol Metab,1994,79(3):750-755.
7[7]Cohen MM,Jr.,Howell RE.Etiology of fibrous dysplasia and McCune-Albright syndrome[J].Int J Oral Maxillofac Surg,1999,28(5):366-371.
8[8]Weinstein LS,Chen M,Liu J.Gs(alpha) mutations and imprinting defects in human disease[J].Ann N Y Acad Sci,2002,96(8):173-197.
9[9]Toyosawa S,Yuki M,Kishino M,et al.Ossifying fibroma vs fibrous dysplasia of the jaw:molecular and immunological characterization[J].Mod Patbol,2007,20(3):389-396.
10[10]Stewart JCB,Fonseca RJ.Oral and maxillofacial surgery[M].Philadelphia:W.B.Saunders Company,2000.